News

American Association of Individual Investors1d
Why Lexicon Pharmaceuticals, Inc.’s (LXRX) Stock Is Down 7.32%
Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 7.32%, which has investors questioning if this is right time to buy.
American Association of Individual Investors2d
Why Lexicon Pharmaceuticals, Inc.’s (LXRX) Stock Is Up 13.42%
Lexicon Pharmaceuticals, Inc.’s LXRX share price has surged by 13.42%, which has investors questioning if this is right time ...
Medical Marketing & Media6d
Rx Rundown: Novo Nordisk, Merck, Eli Lilly and more
Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...